Cas:153863-35-5 (5-METHYL-1-PHENYL-1H-PYRAZOL-4-YL)METHANOL manufacturer & supplier

We serve Chemical Name:(5-METHYL-1-PHENYL-1H-PYRAZOL-4-YL)METHANOL CAS:153863-35-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(5-METHYL-1-PHENYL-1H-PYRAZOL-4-YL)METHANOL

Chemical Name:(5-METHYL-1-PHENYL-1H-PYRAZOL-4-YL)METHANOL
CAS.NO:153863-35-5
Synonyms:1H-Pyrazole-4-methanol,5-methyl-1-phenyl;MFCD02682046;(5-Methyl-1-Phenyl-1H-Pyrazol-4-Yl)Methanol;[(1-phenyl)-5-methyl-1H-pyrazole-4-yl]-methanol
Molecular Formula:C11H12N2O
Molecular Weight:188.22600
HS Code:2933199090

Physical and Chemical Properties:
Melting point:88ºC
Boiling point:346ºC at 760mmHg
Density:1.14g/cm3
Index of Refraction:1.593
PSA:38.05000
Exact Mass:188.09500
LogP:1.67300

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 1H-Pyrazole-4-methanol,5-methyl-1-phenyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[(1-phenyl)-5-methyl-1H-pyrazole-4-yl]-methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole-4-methanol,5-methyl-1-phenyl Use and application,MFCD02682046 technical grade,usp/ep/jp grade.


Related News: The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. 1-(5-chlorobenzo[d]oxazol-2-yl)-3-cyclohexylurea manufacturers Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. 1,3,2-Benzodioxaborole, 2-[(1E)-2-tricyclo[3.3.1.13,7]dec-1-ylethenyl]- suppliers The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. 5-chloro-6-(2,3,5-trifluorophenyl)-N-(1,1,1-trifluoropropan-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine vendor & factory.